Moderna | MRNA - Market Capitalization


Moderna reported $98.11B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.95B 667M Nov/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Moderna USD 99.14B 22.26B Nov/2026
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.17B 85.18M Nov/2026
Qiagen NV USD 10.02B 1.95B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
Vertex Pharmaceuticals USD 142.88B 10.37B Nov/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 76.62B 5.43B Nov/2026